What is Hepatitis C?(NC)-Hepatitis C is an infectious (Cirrhosis)

What is Hepatitis C?

(NC)-Hepatitis C is an infectious virus that is carried in the blood and harms the liver. About 240,000 Canadians are infected, many of whom are unaware that they even have it. The number of people with hepatitis C is increasing in Canada and around the world, primarily among those who share needles and other drug equipment. An estimated 5,000 Canadians - mostly young people - get this virus each year. p>

Although the hepatitis C virus has been around for a long time, it was only identified in 1989. It causes inflammation of the liver, which often progresses to cirrhosis (scarring that makes it difficult for the liver to function normally). Of the estimated 5,000 people that are newly infected each year, up to 70 percent experience no symptoms. For some, symptoms may not show up for 20 or 30 years. In the meantime, they may, unknowingly, be infecting others. That is why it is important to know if you are at risk and how to take preventative action.

If you think you have hepatitis C, or that you may be at risk, visit your doctor and ask for the simple blood test for this disease. For more information, contact a health care professional, and visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.

Treating Chronic Mutational Hepatitis B with Chinese Medicine (Cirrhosis)

Treating Chronic Mutational Hepatitis B with Chinese Medicine Vitalliver (Vigconic Suppositories)

Treating chronic mutational hepatitis B with Chinese medicine Vitalliver (Vigconic suppositories)

ZHANG GUAN HUA, LIANG CHAO, ZHENG WAN PIN

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

Research Method:

Quantitative determination by contrasting HBV-DNA of cases before and after the treatment.

Number of cases: 25 (n)

Case Selection: Between the age of 16 and 65, in accordance with the diagnosis standards pf chronic Hepatitis B, with negative e antigen and positive e antibody, HBV-DNA > 1 104 cp/mL.

Detection Method: All the blood samples are detected by Sichuan Clinical Detection Center; PCR-ELISA quantitative determination is used within detection range of 1 104 - 1 107-8, HBV-DNA, unit of measurement is cp/mL.

Direction Plan: one suppository provided by Vigconic (International) Ltd. Bid. The course of treatment is six months, the tracing observation after withdrawal lasts six months.

Observation index:

1. HBV-DNA response after the treatment.
   

2. Lasting HBV-DNA response (six months after withdrawal).
   p>

Criterion of Therapeutic Effect:

1. If HBV-DNA volume 1 104 cp/mL: 4/25 (16%)
   

2. Lasting response:
   

HBV-DNA volume 1 104 cp/mL: 2/25 (8%)

Among the results of lasting response, 16 blood serum samples are detected through fluorimetric quantitative determination PCR by the instruments of PE.USD, H-7700 in the second attached hospital of Guangzhou Medical College. The result is in accordance with that in Sichuan Clinical Testing Center. (8 cases among it 1 102 cp/mL). The testing range of this testing method is 1 102 - 1 107-8 cp/mL.

Conclusion

The reason for the repeatedly abnormal liver function of Chronic Hepatitis B (CHB) patients lies in the repeatedly duplication of HBV after infection, which leads to fibrosis of liver, then cirrhosis and liver cancer. It is commonly accepted that if CHB shows the transformation of HBeAg/Anti-HBe, HBV-DNA becoming negative, liver function returning to normal state, the disease is relieved. However, parts of patients with the transformation of HBeAg/Anti-HBe still remain positive in HBV-DNA and the pathological change in the liver continues. Because HBV-DNA occurs promoter mutation in the anterior C section (1896 necleoside G-A variation) or in the C section (1762 nucleoside T variation, 1764 G-A variation), HBeAg cannot come into being. Therefore, the HBeAg in the patient s blood cannot be detected, while the virus can keep on duplicating and fixing itself. Through sequential assay of nucleic acid, it proves that promoter mutation appears in 30%-60% of HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section. In some provinces and cities of the People of China, the percentage of promoter mutation appears in HBeAg negative Chronic Hepatitis B (CHB) in the anterior C section or in the C section is from 17.6% to 78.9%. Eight out of the 25 cases of our observation go through the sequential assay of nucleic acid carried out by the Department of Microbiology of the University of Hong Kong. It all proves to have HBV-DNA mutation. The chronic mutational Hepatitis B is infectious and apt to cause cirrhosis and liver cancer since the present medicines of antivirus and immuno-modulator do not produce the expected therapeutic effects.

Vitalliver suppository is made up from a formula of Chinese herbs, including Ginseng, Deer Horn, Cordyceps, Radix Astragali, Frudctus Cnidii, Semen Cuscutae, etc. The formula is mainly for strengthening the body resistant and primarily for reinforcing Kidney Qi, which produces good therapeutic effects in treating chronic mutational Hepatitis B. The mechanism is probably that through the regulating of immune system, the duplication of virus is inhibited and meanwhile the liver is protected, so it can produce a lasting therapeutic effect. No adverse reaction and severe accident happens during clinical observation, so it is safe for using. Vitalliver is bringing hopes to the treatment of chronic mutational Hepatitis B.

* The second stage of clinical trial would be carrying out by the Microbiology Department of the University of Hong Kong and Chengdu University of Traditional Chinese Medicine.

For more information, please visit: http://www.vigconic.com

Or, contact:

William Yip cs@vigconic.com
p>
5/F, Cheung Wah Building, Sheung Heung Rd,

Kowloon, Hong Kong

Tel: 852-27656200

Fax: 852-27645314
p>

Chengdu University of TCM, Hepatitis Laboratory in the attached hospital of Chengdu University of TCM, Sichuan, China

webmaster@vigconic.com

Pill Form of Therapy for HCV Coming Closer (Cirrhosis)

Pill Form of Therapy for HCV Coming Closer
This report is an update of therapy progress presented at the AASLD (American Academy for the Study of Liver Diseases). Three separate approaches are covered. Yes, progress is being made....

Weight-based Treatment of HCV
Weight-based dosing has always made sense to us. We don't really understand why Roche has not changed their dosing to weight-based. Although the difference is subtle, it is certainly significant according to this study. You must also note, though, that...

A Good AASLD Meeting Summary
This is a terrific overview article regarding the AASLD meeting. Liz Highleyman did a fantastic job of condensing the key aspects and announcements. One of the most interesting updates/corrections of known information is the upward measurement of the number of...

Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Fatty Liver
Title: Fatty LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 8/29/2005

Infectious Mononucleosis
Title: Infectious MononucleosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/14/2005

Analysis: India not to deter modernization (Cirrhosis)

Analysis: India not to deter modernization
United Press International - 14 hours agoBy KUSHAL JEENA. NEW DELHI, Feb. 2 (UPI) -- The Indian government needs to stand firm and not go back on economic reforms and modernization programs despite opposition from leftist allies and employees protesting ...

Oscars on a 'Mountain' high
San Bernardino Sun - Feb 1, 2006BEVERLY HILLS - The "Brokeback Mountain" bandwagon picked up more passengers Tuesday morning, as the Academy of Motion Picture Arts and Sciences, as many expected, gave the movie a leading eight Oscar nominations, including one for best picture. ...

Lawmakers grill CMS chief on Part D
Monsters and Critics.com - 5 hours agoBy Laura Gilcrest Feb 3, 2006, 0:10 GMT. WASHINGTON, DC, United States (UPI) -- With Medicare`s Part D drug benefit one month out from a clumsy debut, some new problems are emerging beyond the fiasco of the ...

'US must stop gas guzzling'
Khaleej Times - 38 minutes agoLONDON The United States must put more energy efficient cars on the highway and raise taxes on gasoline if it wants to kick its addiction to oil from the volatile Middle East, analysts said yesterday. ...

Senators square off over wiretapping
Scripps Howard News Service - 3 hours agoBy JAMES ROSEN. WASHINGTON - Senators traded bitter barbs over President Bush's wiretapping initiative Thursday, with Republicans accusing its critics of aiding terrorists and Democrats charging its supporters of violating the Constitution. ...

Feedster (Cirrhosis)

Feedster
No Need to Click Here - I'm just claiming my feed at Feedster....

MedMira Rapid Test
The start of the New Year was accompanied by the European Patent Office granting a patent for a rapid HCV test. Now that the technology is here, let's hope the test proves accurate, with high levels of selectivity and specificity....

Infectious Mononucleosis
Title: Infectious MononucleosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/14/2005

Hepatitis C Virus Lives In Your Liver(NC)-Your liver (Cirrhosis)

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>

Weight envisions a future back with the Blues (Cirrhosis)

Weight envisions a future back with the Blues
SI.com - 2 hours agoST. LOUIS (AP) - A few hours after joining the Carolina Hurricanes, Doug Weight already was plotting his return to the St. Louis Blues. Right now, a Blues' fire sale is in full swing while the owners try to sell the team. ...

Younger: King helped others see best in life
Morris Daily Herald - 32 minutes agoMorris resident Elmo Ray Younger remembered Coretta Scott King today for her strength and stability, and her support of her husband s philosophy of human rights and equality. She will go down in history ...

Denmark tries to curb cartoon anger
Melbourne Herald Sun - 2 hours agoDANISH Prime Minister Anders Fogh Rasmussen expressed alarm today at the wave of anger in the Muslim world prompted by caricatures in a Danish newspapper depicting the prophet Mahommed. He said his government ...

Chafee Takes GOP Maverick Role, Again
Forbes - 49 minutes agoBy ANDREW MIGA , 01.31.2006, 04:34 PM. Rhode Island Sen. Lincoln Chafee, the lone Republican to vote against Samuel Alito's Supreme Court confirmation, has a history of bucking his party on major issues including Iraq, abortion rights and taxes. ...